|
|
|
|||||
Archive:
| |||||
The LICR Melbourne team, together with collaborators from Pacific Edge Biotechnology Limited in New Zealand, has developed a prototype test that can distinguish between these two patient subtypes with 85-90% accuracy ... It was led by investigators from: LICR Melbourne Center Austin Health, Melbourne, Australia; Department of Biochemistry, University of Otago, Otago, New Zealand; Pacific Edge Biotechnology Limited, Dunedin, New Zealand, and; Department of Statistics, University of Auckland,... (EurekAlert!)
The Great American Yard Sale Aug 15, 2008
Switzerland's Roche Holding is offering about $44 billion to acquire the 44% of the biotechnology outfit Genentech that it doesn't own. The surge of foreign buying spans the economy. (Time.com)
Mouse cloned to cure Parkinson's Aug 15, 2008
The embryonic "stem cells", reports the journal Nature Biotechnology, were grown into new tissue which was implanted into the mouse brain. However, many obstacles stand in the way of human treatments, say experts. (Yahoo News -- Parkinson's Disease)
Business: Nanogen to merge with Elitech Group Aug 15, 2008
SAN DIEGO Nanogen, one of San Diego's older biotechnology companies, announced Thursday that it will merge with the Elitech Group, a privately owned diagnostics company based in Paris, in an all-stock transaction. The exact value of the deal was not provided by the companies. (San Diego Union-Tribune)
SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms Aug 14, 2008
About SGX Pharmaceuticals SGX Pharmaceuticals, Inc. is a biotechnology company focused on the discovery, development and commercialization of novel, targeted therapeutics directed at addressing unmet medical needs in oncology ... In addition, results may be affected by the failure to enter into new collaborations on any of its research and development programs in the event that the merger transaction is not consummated, competition from other biotechnology and pharmaceutical companies, its... (PR Newswire)
Genentech turns down Roche offer Aug 14, 2008
Genentech is the world's biggest biotechnology company by market value. A large part of its revenue comes from cancer related drugs. (BBC News -- Americas)
PolyMedix gets OK for human testing of anticoagulant Aug 14, 2008
biotechnology company describes as an entirely new class of drug called heptagonists. PolyMedix (OTCBB: PYMX), which is focused on developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, is attempting to commercialize technology licensed from the University of Pennsylvania. (Philadelphia Business Journal, PA)
Biotech Campaigns for Easier Access to Generic Drug Market Aug 14, 2008
Geoffrey Allan has been giving Congress a lesson in biotechnology. He's explained protein structures and how they work. (Washington Post -- Technology)
Missing the signs Aug 14, 2008
Almost exactly four years ago, I was in Cologne, Germany to cover the Agricultural Biotechnology International Conference (Abic). Scientist after scientist (many of them working in the commercial sector) told me how companies had messed up by appearing to force GM products on an unsuspecting world, and how narrow the lines of research had been. (BBC News -- UK)
Biotech Battle Brewing? Aug 14, 2008
Biotechnology was born in 1976 when Genentech was founded as the first company to make use of gene-splicing techniques to manufacture drugs ... Genentech, which grew rapidly on the strength of cancer drugs such as Avastin, is the largest biotechnology company in the world by market capitalization. (San Francisco Chronicle -- Business)
American Seeds, Inc., plants seeds of choice Aug 14, 2008
The benefits of biotechnology include offering a higher quality of life for many farm families, greater herbicide application flexibility, methods to protect and maximize yield potential, greater on-farm convenience, reductions in pesticide use, and reductions in costs associated with farming ... Since the introduction of biotechnology in corn beginning in 1996, U.S. corn yields have increased an average of 32 bushels by 2008, Stern said ... In soybeans, greater yields are also expected through... (Minnesota Farm Guide, MN)
News Stories Aug 14, 2008
Biotechnology and Genetics Full Coverage on Yahoo. News. (Yahoo News -- Biotechnology and Genetics)
Five-step check for nano safety Aug 14, 2008
The group of experts says that if the global research community can take advantage of the safety infrastructure already in place for biotechnology and computing, then nanotechnology has a rosy future. But Dr Maynard, from the Woodrow Wilson International Center for Scholars in Washington DC, and colleagues say that the way science is carried out means it is ill-equipped to address novel risks from emerging technologies. (Yahoo News -- Nanotechnology)
Genentech Rejects Roche Bid but Willing to Talk Aug 14, 2008
Genentech, the world's biggest biotechnology company by market value, said the Swiss drugmaker's offer of $89 a share "substantially undervalues the company." But it said it would consider an offer that "reflects the significant benefits that would accrue to Roche as a result of full ownership.". Investors had expected Genentech to reject Roche's initial bid, which was made last month and values the stake at $43. (ABC News -- Wire)
Scientists condemn 'ill-informed, negative' Prince over GM crops ... Aug 14, 2008
They also ridiculed his contention that agricultural biotechnology was contributing to major challenges such as global warming ... Though the Government, plant scientists and industry are promoting GM crops as part of the solution to global food shortages, the Prince said that biotechnology had already proved itself a dangerous failure ... Julian Little, chairman of the Agricultural Biotechnology Council, an industry group, linked the Prince's views to his interest in organic farming. (Times Online)
* Its time for the US to choose healthy growth and social justice Aug 14, 2008
Government laid the foundations of the Internet and the modern biotechnology revolutions. In the 19th century, research at US government-supported universities provided the basis for the agricultural revolution. (Taipei Times, Taiwan -- World)
* Combined first-half revenues at science parks rise 17.2% Aug 14, 2008
49 billion and biotechnology with NT$3. 77 billion. (Taipei Times, Taiwan -- World)
ImClone hints at dim view of Bristol-Myers offer Aug 14, 2008
In June, Icahn lost his ImClone-style takeover bid for fellow biotechnology company Biogen Idec Inc. He attempted to put three of his nominees on the board of directors in the hopes that it would eventually trigger a sale, but shareholders voted instead for the current board's nominees. ImClone shares fell 31 cents to $65. (Yahoo News -- Pharmaceutical Industry News)
Roche in $43.7bln bid for remaining Genentech shares Aug 14, 2008
9 percent of the biotechnology company, will offer 89 dollars a share to equity holders of Genentech, the group said in a statement. The move would bring annual pre-tax savings worth between 750 and 850 million dollars, the company said. (Yahoo News -- Pharmaceutical Industry News)
Genentech mulls Roche offer as stock surges Aug 14, 2008 Roche offers $43.7B for rest of Genentech Aug 14, 2008 Bristol-Myers seeks to buy remainder of ImClone Aug 14, 2008 Bristol-Myers offering $4.5 billion for ImClone Aug 14, 2008 Robot Controlled By Biological Brain Aug 14, 2008 Genentech rejects takeover bid from Roche Aug 14, 2008 For Clinton, New Wealth In Speeches Aug 14, 2008 Baucus talks trade with ambassadors Aug 14, 2008 Genentech coy about Roche bid Aug 14, 2008 Genentech says Roche proposal undervalues company Aug 14, 2008 Avantair, Inc. to Present At the Fourth Annual Noble Financial Equity Conference Aug 14, 2008 GM potato trials given go-ahead Aug 14, 2008 Genetically Engineered Rice Wins USDA Approval Aug 14, 2008 U.S. Uneasy About Biotech Food Aug 14, 2008 U.S. biotech company rejects Swiss buyoff bid Aug 14, 2008 New to the Stable: Two Champion Clones Aug 14, 2008 Greenspan Bites Back Aug 14, 2008 Bringing Martian samples to Earth -- preparations outlined in journal Astrobiology Aug 14, 2008 Biotech industry spreading Aug 13, 2008 Tied up over disclosure Aug 13, 2008 BioMS Medical Announces Second Quarter 2008 Results Aug 13, 2008 Roche offers $43.7B for rest of Genentech Aug 13, 2008 Bristol-Myers seeks to buy remainder of ImClone Aug 13, 2008 ImClone hints at dim view of Bristol-Myers offer Aug 13, 2008 Bristol offers to buy ImClone for $60 a share Aug 13, 2008 Genentech mulls Roche offer as stock surges Aug 13, 2008 Roche in $43.7bln bid for remaining Genentech shares Aug 13, 2008 Bristol-Myers offering $4.5 billion for ImClone Aug 13, 2008 Aphids Are Sentinels Of Climate Change Aug 13, 2008 RTI signs $80M deal for work in Abu Dhabi Aug 13, 2008 Adherex Reports Second Quarter 2008 Financial Results Aug 13, 2008 Careful with that globe Aug 13, 2008 These Stocks Beat Biotech Stocks Aug 13, 2008 Government to set up Youth Enterprise Fund Aug 13, 2008 Lexicon Pharmaceuticals Identifies New Drug Candidate for Glaucoma Aug 13, 2008 Australian rival to buy Talecris Aug 13, 2008 Shares close lower Aug 13, 2008 Biotechnology program awarded $245,300 grant Aug 13, 2008 Genentech rejects Roche's $43.7 billion bid Aug 13, 2008 Scientists use old enemy to K.O. cancer Aug 13, 2008 Mouse cloned to cure Parkinson's Aug 13, 2008 Stop & Shop recalls tuna salad over Listeria fears Aug 12, 2008 Sales Contracts Worth $2.3 Million Signed Since 1 July 2008 Aug 12, 2008 Bronchitol Cystic Fibrosis Dose Trial Results Positive Aug 12, 2008 Migenix averts proxy contest; reaches agreement with DJohnson holdings Aug 12, 2008 Enzon's Split Ends Aug 12, 2008 Cuba approves first therapeutic vaccine for lung cancer Aug 12, 2008 News Stories Aug 12, 2008 Icahn Ups Stake in Biogen, Says Stock Undervalued Aug 12, 2008 What If the FBI Is Right Aug 12, 2008 Applied Robotics looks to biotech, food sectors Aug 12, 2008 * Hsinchu Science Park production rises 4.25% Aug 12, 2008 Ricin's Deadly Action Revealed By Glowing Probes Aug 12, 2008 For Clinton, New Wealth In Speeches Aug 12, 2008 Pharmacokinetics Study Confirms Therapeutic-Enabling Quantities of Allon's Drugs AL-108 and AL-208 in Human Cerebrospinal Fluid Aug 12, 2008 OrthoLogic's listing on Nasdaq threatened Aug 12, 2008 'A serial entrepreneur' Aug 12, 2008 BioMimetic reports $9M Q2 loss Aug 12, 2008 Sports doping detection a never-ending science Aug 12, 2008 Generex Announces Enrollment of Over 150 Patients in Phase III Trial of Generex Oral-lyn Aug 12, 2008 Threshold Pharmaceuticals Initiates a Second Clinical Trial Evaluating TH-302 in Patients With Solid Tumors Aug 12, 2008 U.S. Uneasy About Biotech Food Aug 12, 2008 Genetically Engineered Rice Wins USDA Approval Aug 12, 2008 GM potato trials given go-ahead Aug 12, 2008 China to host int'l advanced materials summit Aug 12, 2008
SAN FRANCISCO - Biotechnology pioneer Genentech Inc. mulled Roche Holding's $43. 7 billion offer for its remaining shares Monday as investors made clear their feelings that the Swiss pharmaceutical giant should pay considerably more. (Yahoo News -- Pharmaceutical Industry News)
Bristol offers to buy ImClone for $60 a share Aug 14, 2008
Shares of other biotechnology companies with pharmaceutical partners, including Amylin Pharmaceuticals Inc (AMLN.O) and Onyx Pharmaceuticals (ONXX.O), rose sharply after news of Bristol's offer. A buyout would be the latest twist in ImClone's colorful history. (Yahoo News -- Pharmaceutical Industry News)
The company said its earlier investment in Genentech had helped the biotechnology company focus on innovation and long-term projects, "leading to some of the most important breakthroughs in the treatment of cancer and other life-threatening diseases.". Roche codevelops and markets Genentech products outside North America. (Yahoo News -- Pharmaceutical Industry News)
NEW YORK (AFP) - Bristol-Myers Squibb, the US pharmaceuticals group, said Thursday it has offered to buy its biotechnology partner ImClone Systems in an all-cash deal worth around 4. 5 billion dollars. (Yahoo News -- Pharmaceutical Industry News)
5 billion in cash for its cancer drug partner, biotechnology company ImClone Systems Inc., saying the two are "a natural fit.". ADVERTISEMENT. (Yahoo News -- Pharmaceutical Industry News)
16, 2005) This week scientists of the Flanders Interuniversity Institute for Biotechnology (VIB) will once again publish a breakthrough in their research regarding Alzheimer's disease. The researchers. (Science Daily)
The biotechnology company Genentech, as expected, on Wednesday turned down a buyout offer from its majority owner, Roche, saying the $43 ... Mark Schoenebaum, biotechnology industry analyst at Deutsche Bank, said that Genentech's response contained "no major surprises" and that the statement "appears friendly to us." Therefore, he said, "consummation of a deal continues to seem likely to us." ... Roche first bought a majority stake in Genentech, a pioneering biotechnology company, in 1990, and... (International Herald Tribune -- Business)
His paid speeches included $150,000 appearances before landlord groups, biotechnology firms and food distributors, as well as speeches in England, Ireland, New Zealand and Australia that together netted him more than $1. 6 million. (Yahoo News -- Bill Clinton)
They explored biotechnology in the Bitterroot Valley, and electronics on the reservation. They visited the University of Montana and marveled at an educational exchange agreement with Vietnam. (Missoulian, MT)
A plan by drugmaker Roche to take over biotechnology giant Genentech and move Roche's U.S. headquarters from New Jersey to California suffered a setback yesterday when Genentech turned down the offer. But while rejecting Roche's $43. (NJ.com -- Times)
Biotechnology company said Wednesday a special committee has unanimously concluded that a $43. 7 billion bid by Group AG "substantially undervalues" the company. (East Bay Business Times, CA)
The Fourth Annual Noble Financial Equity Conference will feature presentations by 150 small-cap companies in a variety of industries, including: Biotechnology, Business and Consumer Services, Healthcare and Medical Technology and Media, Entertainment and Gaming. The conference's goal is to uncover and showcase the value embedded in orphaned, undiscovered or misunderstood companies. (Primezone Releases)
The biotechnology firm applied to the Department for Environment, Food and Rural Affairs (Defra) to hold trials at the headquarters of the National Institute of Agricultural Botany (NIAB) in Cambridge and on a farm at Draycott in Derbyshire. The GM potato crops are to be planted next spring, and trials will last several years. (Yahoo News -- Genetically Modified Food)
Joseph Mendelson, legal director of the nonprofit Center for Food Safety, said the quick approval shows that the USDA is more concerned about the fortunes of the biotechnology industry than about consumers' health. "USDA is telling agricultural biotechnology companies that it doesn't matter if you're negligent, if you break the rules, if you contaminate the food supply with untested genetically engineered crops, we'll bail you out," Mendelson said in a statement. (Yahoo News -- Genetically Modified Food)
Few Americans favor the introduction of genetically modified foods, while many do not realize how widespread they already are, according to a Pew Initiative on Food and Biotechnology poll ... Michael Fernandez, executive director of the Pew Initiative on Food and Biotechnology, which sponsored the survey, said that overall, Americans are "still generally uncertain" about genetically modified and cloned foods. (Yahoo News -- Genetically Modified Food)
LOS ANGELES, Aug. 13 (Xinhua) -- Genentech rejected on Wednesday a 44-billion-dollar bid by Roche of Switzerland to take complete control of the San Francisco-based biotechnology company. Genentech board members recommended against the buyout bid at a meeting Wednesday morning, the company said in a statement. (Xinhuanet, China)
View a Sample and Sign Up. World of Thoroughbred Racing Plans to Shun Breeding Venture. (Yahoo News -- Cloning)
7 billion takeover bid by Swiss majority owner Roche while noting that the California biotechnology wiz is playing hard to get. "Genentech said that a special committee of directors had found that Roche's offer of $89 a share 'substantially undervalues the company,' " writes the NYT. Roche's three biggest-selling drugsthe cancer medicines Rituxan, Herceptin, and Avastinare produced by Genentech, and while the two connected companies once had been seen to complement each other, their... (Slate)
Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research Its biotechnology trade magazine, Genetic Engineering chnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, books, and newsmagazines is available at. (EurekAlert!)
Long centered in Cambridge with access to the scientists at Harvard and MIT, the biotechnology industry, working primarily on the development of new medicines, has been moving outward over the past seven years to the Route 128 corridor, where rents are considerably lower ... Patriot Partners wants to change that, making biotechnology the focus of the industrial component of the Land Locked Parcel development ... Another element that has not been in Burlington s interest has been the tendency for... (Burlington Union, MA)
"I am not so much worried about Genzyme or the drug industry in Massachusetts as about academic medical centers," said Roger Louis, chief compliance officer for the Cambridge biotechnology company, adding that it's unclear what the final rules will say ... Mark Leuchtenberger, chairman of the Massachusetts Biotechnology Council, said in a statement: "Companies will no doubt reconsider whether to relocate, expand, or do business with Massachusetts.". (Boston Globe)
"During the quarter, BioMS was also honored to receive the Gold Leaf Award from BIOTECanada in recognition of our selection as "Company of the Year". Currently, BioMS is conducting three clinical trials and one open-label follow-on trial for MBP8298 (dirucotide): (x) MAESTRO-01: A randomized, double-blind pivotal phase II/III trial in Canada and Europe evaluating MBP8298 (dirucotide) for the treatment of secondary progressive MS (SPMS). The study has completed full recruitment of 611 patients at... (PR Newswire)
The company said its earlier investment in Genentech had helped the biotechnology company focus on innovation and long-term projects, "leading to some of the most important breakthroughs in the treatment of cancer and other life-threatening diseases.". Roche codevelops and markets Genentech products outside North America. (Yahoo News -- Pharmaceutical Industry News)
NEW YORK (AFP) - Bristol-Myers Squibb, the US pharmaceuticals group, said Thursday it has offered to buy its biotechnology partner ImClone Systems in an all-cash deal worth around 4. 5 billion dollars. (Yahoo News -- Pharmaceutical Industry News)
In June, Icahn lost his ImClone-style takeover bid for fellow biotechnology company Biogen Idec Inc. He attempted to put three of his nominees on the board of directors in the hopes that it would eventually trigger a sale, but shareholders voted instead for the current board's nominees. ImClone shares fell 31 cents to $65. (Yahoo News -- Pharmaceutical Industry News)
Shares of other biotechnology companies with pharmaceutical partners, including Amylin Pharmaceuticals Inc (AMLN.O) and Onyx Pharmaceuticals (ONXX.O), rose sharply after news of Bristol's offer. A buyout would be the latest twist in ImClone's colorful history. (Yahoo News -- Pharmaceutical Industry News)
SAN FRANCISCO - Biotechnology pioneer Genentech Inc. mulled Roche Holding's $43. 7 billion offer for its remaining shares Monday as investors made clear their feelings that the Swiss pharmaceutical giant should pay considerably more. (Yahoo News -- Pharmaceutical Industry News)
9 percent of the biotechnology company, will offer 89 dollars a share to equity holders of Genentech, the group said in a statement. The move would bring annual pre-tax savings worth between 750 and 850 million dollars, the company said. (Yahoo News -- Pharmaceutical Industry News)
5 billion in cash for its cancer drug partner, biotechnology company ImClone Systems Inc., saying the two are "a natural fit.". ADVERTISEMENT. (Yahoo News -- Pharmaceutical Industry News)
This work is reported in BBSRC Business, the quarterly research highlights magazine of BBSRC (the Biotechnology and Biological Sciences Research Council). Adapted from materials provided by. (Science Daily)
In 2006, RTI signed a deal with the Biotechnology and Research Park in Dubai to help develop scientific and regulatory standards in the Middle Eastern life sciences industry. Under terms of its agreement with the Abu Dhabi government, RTI will provide various types of aid to the government s environmental workers. (Raleigh Triangle Business Journal, NC)
ADH-1 is a biotechnology compound which selectively targets N-cadherin, a protein present on certain tumor cells and the blood vessels of solid tumors. STS is a chemoprotectant being developed to reduce or prevent hearing loss that may result from treatment with platinum-based chemotherapy drugs. (CCNMatthews Press Releases)
Ethical and philosophical issues have long occupied biotechnology, where institutional review boards commonly rule on proposed experiments and advisory committees must approve the use of gene-splicing and related techniques ... The meeting, at the Asilomar conference center in California, gave rise to an ethical framework that still prevails in biotechnology. (International Herald Tribune)
Clicking the Biotechnology tag pulls up a list of 294 stocks that have gained 19. 8% in the past year. (MSNBC -- Business)
He also urged government to encourage the use of environmentally friendly technologies such as biotechnology and to give incentives to industries that adopted innovative ways in managing emissions. Mr Ohemeng also charged district assemblies to educate residents on the environment to forestall the global warming threat. (Ghana Web, Ghana)
Biotechnology Headlines. More Finance RSS Feeds. (Primezone Releases)
Advertisements Sabine Vollmer, Staff Writer Talecris Biotherapeutics, one of the Triangle's largest biotechnology companies, agreed to be bought by a bigger rival, CSL Ltd. of Australia, for $3. 1 billion. (News & Observer)
ASX: latest Australian share market news. Welcome to The Sydney Morning Herald. (Sydney Morning Herald -- Business)
The Amgen Foundation has given a $245,300 grant to a biotechnology program that provides training and support to science teachers and students in the region. The grant was made to the San Diego Workforce Partnership and the Southern California Biotechnology Center at Miramar College ... The money will fund the Amgen-Bruce Wallace Biotechnology Lab program throughout the San Diego area over the next three years. (San Diego Union-Tribune -- Business)
NEW YORK Biotechnology giant Genentech is turning down a buyout offer from its majority owner Roche, saying the $43. 7 billion takeover bid undervalues the company. (San Diego Union-Tribune -- Business)
" Scientists working on the project now hope to move the research out of the laboratory the next stage for this work would be medical trials. ### The research was funded the Biotechnology and Biological Sciences Research Council (BBSRC), and the findings are published in the Proceedings of the National Academy of Sciences - August 2008.. (EurekAlert!)
The embryonic "stem cells", reports the journal Nature Biotechnology, were grown into new tissue which was implanted into the mouse brain. However, many obstacles stand in the way of human treatments, say experts. (Yahoo News -- Parkinson's Disease)
5 million shares of the Cambridge-based biotechnology company, according to a filing with the Securities and Exchange Commission ... 2d-quarter loss widens on higher costs Biotechnology company ArQule Inc., which focuses on cancer therapies, said its second-quarter loss widened on higher clinical development costs. (Boston Globe)
The tests are sold to pharmaceutical, biotechnology, nutraceutical and functional food companies to quantify the effect of drugs or other interventions on human subjects participating in clinical trials. Since sales into the clinical trials market began in 2004, CogState has secured agreements with organizations including Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Abbott Laboratories, Centres for Disease Control (USA), ALZA Corporation (a member of the Johnson and Johnson group), Lundbeck and... (PR Newswire)
About the Trial The following information is provided in accord with the ASX and AusBiotech Code of Best Practice for Reporting by Biotechnology, Medical Device and other Life Sciences Companies. Name of Trial DPM-CF-202 (a Phase II study with Bronchitol) Blinding Status Open Design Crossover, Dose response Treatment Route Inhalation Frequency Twice daily Dose levels 400mg, 240 mg, 120 mg, 40 mg for 2 weeks, 1-2 weeks washout between doses No of subjects PP population 38 Subject Selection... (PR Newswire)
Bruce Schmidt - Mr. Schmidt is a founder and chief executive officer of a University of British Columbia spin-off biotechnology company focused on novel compounds for the treatment of various cancers and neurological disorders ... Mr. Rae has spent a decade in the biotechnology industry, formerly as chief financial officer with Ability Biomedical Corporation ... Previously, Mr. Rae served as biotechnology equities analyst at Goepel Shields ers (now Raymond James Ltd.), covering Canadian... (PR Newswire)
In May, Enzon announced the spin-off of its biotechnology unit ... "During our efforts to spin-off our biotechnology business, it became clear that we should also explore attractive opportunities for Enzon's other businesses.". (Forbes -- Markets)
The therapeutic vaccine CimaVax EGF extends life with few side effects, and is another step in Cuba's expertise in biotechnology ... Fidel Castro championed biotechnology in the 1980s; by the 1990s Cuba had produced and marketed vaccines for meningitis B and hepatitis B.. (Yahoo News -- Cancer)
Biotechnology and Genetics Full Coverage on Yahoo. News. (Yahoo News -- Biotechnology and Genetics)
03 percent stake in the common stock of biotechnology company Biogen Idec Inc. Icahn said in a filing with the U.S. Securities and Exchange Commission that he increased his stake "in the belief that the shares were undervalued." He said his funds may acquire additional Biogen shares, debt or other equity. (ABC News -- Wire)
Since then, the intelligence community has been aware that revolutionary advances in biotechnology now provide nonstate actors with the potential to build and deliver highly sophisticated bioweapons. This was stated in an unclassified Defense Science Board report in June 2001, and repeated by virtually every subsequent government and think-tank assessment. (Wall Street Journal)
Applied Robotics has moved into the biotechnology sector and into other smaller industries, such as food and beverage manufacturing ... Biotechnology, though, is an even greater prize because of the high demand for robotics. (Albany Business Review, NY)
604 billion, and the biotechnology industry, down 6. 83 percent to NT$1. (Taipei Times, Taiwan -- World)
Biotechnology researchers discovered that ricin. (Dec. (Science Daily)
His paid speeches included $150,000 appearances before landlord groups, biotechnology firms and food distributors, as well as speeches in England, Ireland, New Zealand and Australia that together netted him more than $1. 6 million. (Yahoo News -- Bill Clinton)
Allon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. In Q1 2008, Allon's drug AL-108 demonstrated human efficacy in amnestic mild cognitive impairment, a precursor to Alzheimer's disease. (CCNMatthews Press Releases)
The Tempe-based biotechnology company received the letter Friday because its share price closed below the $1 minimum bid for 30 consecutive days. It must maintain a minimum closing bid of $1 for 10 consecutive business days by Feb. 4 in order to keep its listing on the Nasdaq. (AZCentral -- Business)
Abe Abuchowski, a pioneer in New Jersey's biotechnology industry, has a sober, smart business plan for his latest venture, Prolong Pharmaceuticals. The biochemist helped develop a drug delivery technology, called pegylation, that makes existing medicines more effective and played a key role in the founding of Enzon Pharmaceuticals a quarter-century ago. (NJ.com -- Times)
The Franklin-based biotechnology company reported net income of $22. 1 million, or $1. (Nashville Business Journal, TN)
But authorities fear that drug suppliers soon will move beyond steroids and stimulants and make use of cutting-edge biotechnology techniques such as gene therapy and chemical gene inhibition. For example, crooked athletes might inject extra genes that help create EPO in the body. (San Francisco Chronicle)
Source: Generex Biotechnology Corp. ... Aug. 12, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has enrolled over 150 patients in the Company's pivotal Phase III clinical trial of Generex Oral-lyn(tm), its flagship proprietary oral insulin spray product ... About Generex Biotechnology Corporation. (Primezone Releases)
Threshold is a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of cancer ... Biotechnology Headlines. (Primezone Releases)
Few Americans favor the introduction of genetically modified foods, while many do not realize how widespread they already are, according to a Pew Initiative on Food and Biotechnology poll ... Michael Fernandez, executive director of the Pew Initiative on Food and Biotechnology, which sponsored the survey, said that overall, Americans are "still generally uncertain" about genetically modified and cloned foods. (Yahoo News -- Genetically Modified Food)
Joseph Mendelson, legal director of the nonprofit Center for Food Safety, said the quick approval shows that the USDA is more concerned about the fortunes of the biotechnology industry than about consumers' health. "USDA is telling agricultural biotechnology companies that it doesn't matter if you're negligent, if you break the rules, if you contaminate the food supply with untested genetically engineered crops, we'll bail you out," Mendelson said in a statement. (Yahoo News -- Genetically Modified Food)
The biotechnology firm applied to the Department for Environment, Food and Rural Affairs (Defra) to hold trials at the headquarters of the National Institute of Agricultural Botany (NIAB) in Cambridge and on a farm at Draycott in Derbyshire. The GM potato crops are to be planted next spring, and trials will last several years. (Yahoo News -- Genetically Modified Food)
Tianjin Municipal People's Government, ChemChina, the Society for Chemical Engineering and Biotechnology and Morgan Stanley are co-organizing the event. Participants will discuss subjects including "enterprises and social responsibilities," "opportunities and investment strategies" and "technology and research directions" during the conference. (Xinhuanet, China)
Back to Biology News
©1998-2008 SurfWax, Inc.
All rights reserved. Patents pending.
Copyright SurfWax, Inc. 2008 |